Live Company Group PLC (LON:LVCG) has highlighted “strong growth” in the first two months of 2020 as well as two new contracts for its BRICKLIVE events. In a trading update for the year since mid-January, the media firm said it has secured £3.2mln in contracted revenues for the year as well as £1.1mln for 2021.
EQTEC PLC (LON:EQT) has inked an agreement that envisages the development of the first advanced gasification plant in Greece. A memorandum of understanding covered key terms of a proposed co-operation with regional companies – Eco Hellas and Agrigas Energy.
Location Sciences Group PLC (LON:LSAI) has signed a global master service agreement with one of the largest global advertising holding companies for its anti-fraud platform. The agreement follows multiple tests carried out at the end of 2019 using the Verify platform. Location Sciences has also signed a partnership agreement with Horizon Media, one of the world’s leading independent media agencies.
Adamas Finance Asia Limited (LON:ADAM) has placed 1.64mln with a syndicate of three third-party investors at a price of 16.1p for an aggregate consideration of £203,500. The price is the same as the company paid when it acquired the shares on 23 December 2019.
88 Energy Ltd (LON:88E) confirmed it has kicked off drilling at the Charlie-1 appraisal well on Alaska’s North Slope. The well programme is partnered with Premier Oil PLC (LON:PMO) which is largely funding the venture that aims to test a potentially significant discovery previously unearthed by BP back in the 1990’s.
Haydale Graphene Industries PLC (LON:HAYD) has won a gig with the English Institute for Sport (EIS) to produce high-performance kit coated with graphene. The company first announced a hook-up with the EIS back in September 2018, and after the completion of the initial prototype testing, Haydale will collaborate with the Welsh Centre for Printing and Coating (WCPC) to deliver a range of advanced wearable technology sportswear for elite athletes.
ANGLE PLC (LON:AGL) said researchers have developed a further potential use for its liquid biopsy – this time in the early detection of the spread of lung cancer to the brain. Parsortix, which harvests tiny circulating tumour cells, has been used to assess better treatment options in a range of cancers including breast and prostate.
Vast Resources PLC (LON:VAST) jumped 20% after the Zimbabwe mining ministry said it will finalise its side of the Chiadzwa joint venture in the Marange diamond fields this month. Vast has received official communication from the Ministry of Mines and Mining Development to the effect that all internal processes leading to the conclusion of the Joint Venture are expected to be finalised during the month of March 2020, it said in a statement.
SkinBioTherapeutics PLC (LON:SBTX) said the first half of its financial year saw the skin health life sciences company begin to commercialise its technology. The management team is targeting further commercial progress in the areas of MediBiotix, where it is focusing on medical device applications, and CleanBiotix during the course of the year.
Sativa Group PLC (NEX:SATI) said the UK government’s decision this week to allow faster access to prescribed cannabis-based medicines shows the country is “fast-developing as a significant medicinal cannabis market”. From Monday 2 March, the Department of Health and Social Care and the Home Office said import restrictions have been lifted to help ensure people with medical prescriptions for cannabis-based do not have their treatment delayed or interrupted.
Braveheart Investment Group PLC (LON:BRH), the fund management and strategic investment group has launched its new-look website. The website, www.braveheartgroup.co.uk, now includes comprehensive information about its strategic investments.
APQ Global Limited (LON:APQ) has agreed its second deal of the year – the acquisition of Delphos International, the Washington DC-based financial advisor that shares APQ’s emerging markets focus. The Investment group is paying an upfront US$1.5mln along with up to four further earn-out payments between now and June 2022 – three capped at a maximum US$750,000 and the other at a US$500,000 maximum.
Iconic Labs PLC (LON:ICON) said it is now generating revenues and expects growth to continue “significantly” across 2020. In a trading update, the media and technology firm said its business was continuing to show “early signs of growth” with two contracts announced and other opportunities currently under discussions.
Norman Broadbent PLC (LON:NBB) has expanded its operations in Northern England with the opening of a new office in Cheshire county. The recruitment firm said the new office, opened in response to “increasing client demand”, will provide a local team to serve clients across the North as well as in Scotland.
Iofina PLC (LON:IOF) says it has not received a formal requisition from Brexiteer Arron Banks for a general meeting (GM) to change the board at the iodine and hemp producer. Proposals to replace non-executive chairman Lance Baller and appoint Banks and two of his supporters were posted on Twitter by an associate of the Leave EU man. In a statement, Iofina said: “The company confirms that, at this time, it has not received a requisition for a GM.”
Regency Mines PLC (LON:RGM) has submitted an application for grid connection for its first flexible grid solutions project in Southport. “Application for the grid connection is a critical step forward towards financial close at our first project in Southport,” said Regency chief executive Scott Kaintz in a statement. “With this key objective now completed, the company remains on target for maiden revenues by end of 2020,” he added.
Arix Bioscience PLC (LON:ARIX) said its stake in the sickle cell therapies specialist Imara Inc would be worth US$21.9–US$24.6mln at the proposed US IPO price range of US$16–US$18 a share. Arix also said it was interested in purchasing common shares in the offering, “subject to agreement with the underwriters”.
InnovaDerma PLC (LON:IDP), a UK developer of beauty, personal care and life sciences products, said it was notified today that Joseph Bayer, its executive chairman has purchased 16,400 ordinary shares in the company at a price of 58p each. Following the purchase, the group added, Bayer personally now holds a total of 49,240 shares, and also has a separate holding of 129,000 ordinary shares held via his Australian Superannuation Fund, meaning his total interest in the company through direct and indirect holdings is 178,240 shares representing approximately 1.23% of its issued share capital.
United Oil & Gas PLC (LON:UOG) shares could be worth substantially more than the current price in the wake of its Egyptian acquisition, that’s the view of house broker Optiva. The AIM-quoted oil and gas firm last week completed its acquisition of a 22% non-operated stake in the Abu Sennan concession from Rockhopper Exploration PLC (LON:RKH).
Arkle Resources PLC (LON:ARK), the Irish gold and zinc exploration and development company, said it will be presenting at the Ireland forum at PDAC on 3 March 2020 at the Metro Convention Centre, Toronto, Canada. Patrick Cullen, Arkle’s chief executive officer commented, “PDAC brings together some of the leading mining companies and investors, providing an excellent forum to present and meet. We are here in response to interest from third parties that have reviewed our gold and zinc portfolio. Some of these discussions continue in response to the Stonepark Zinc strategic review announced at the end of 2019. He added: “We are also very pleased to have been invited by Geoscience Ireland, Geological Survey Ireland and Enterprise Ireland to present at the Ireland Day ‘Ireland: open for business’. There has been a strong Irish presence at PDAC for many years and senior Irish government officials are in attendance this year again.”
Scancell Holdings PLC (LON:SCLP), the developer of novel immunotherapies for the treatment of cancer, said its Chief Scientific Officer and Professor of Cancer Immunotherapy at the University of Nottingham, Professor Lindy Durrant will be presenting at the following three conferences in March 2020: The Cambridge Healthcare Institute’s (CHI) Immuno-Oncology Summit Europe 2020 in London (9-12 March 2020); The 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress in London (12-13 March 2020; and The 5th Skin Vaccination Summit 2020 in Edinburgh (17-19 March 2020). The group said the presentations by Professor Durrant will highlight the recent progress made across the company’s technology platforms including Moditope and AvidiMab. The poster presentations are available on the company’s website.
Woodbois Limited (LON:WBI), the African-focused forestry and timber trading company, announced the release of its latest corporate presentation which is available from the investor centre of the company’s website.
SigmaRoc PLC (LON:SRC), the AIM-listed buy-and-build construction materials group, has announced share buying by certain directors on 2 March 2020. It said David Barret, its executive chairman purchased 145,000 ordinary shares at a price of 42.5p each; Max Vermorken, its chief executive officer purchased 10,204 ordinary shares at a price of 43p each; and Garth Palmer, its chief financial officer purchased 117,096 ordinary shares at an average price of 42.7p each. In addition, shares were also purchased by: Charles Trigg, the firm’s technical director, David McClelland, managing director of South Wales; Emmanuel Maes, managing director of Benelux Aggregates; and Dean Masefield, finance director of Ronez.
BB Healthcare Trust PLC (LON:BBH) said it has issued 1,350,000 of its ordinary shares under its block listing facility at a price of 142.0p each, a premium to the group’s prevailing net asset value (cum income) per ordinary share.